Mertansine Options
Pharmacological inhibition in the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; also referred to as FRAP-linked protein (FRP1)) has emerged like a promising strategy for cancer procedure that exploits synthetic lethal interactions with proteins involved with DNA problems fix, overcomes resistance to other therapies